Bromotetrandrine is an P-glycoprotein inhibitor, which were developed and coadministered with chemotherapeutic drugs to overcome the effect of efflux pumps thus enhancing the chemosensitivity of therapeutics.

62067-29-2

C38H41BrN2O6

701.65

W198;W 198;W-198;5-Bromotetrandrine;BrTet;Bromotetrandrine

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years